36 results on '"Fathizadeh, Hadis"'
Search Results
2. Long non-coding RNAs and gastric cancer: An update of potential biomarkers and therapeutic applications
- Author
-
Hosseini, Sayedeh Azimeh, Haddadi, Mohammad Hossein, Fathizadeh, Hadis, Nemati, Foroogh, Aznaveh, Hooman Mahmoudi, Taraj, Farima, Aghabozorgizadeh, AmirArsalan, Gandomkar, Golmaryam, and Bazazzadeh, Elaheh
- Published
- 2023
- Full Text
- View/download PDF
3. Designing a novel fusion protein from Streptococcus agalactiae with apoptosis induction effects on cervical cancer cells
- Author
-
Marzhoseyni, Zeynab, Shayestehpour, Mohammad, Salimian, Morteza, Esmaeili, Davoud, Saffari, Mahmood, and Fathizadeh, Hadis
- Published
- 2022
- Full Text
- View/download PDF
4. Evaluation of the effect of Saccharomyces cerevisiae on the expression of enterotoxin genes in Escherichia coli O157: H7 (EHEC) and Escherichia coli H10407 (ETEC)
- Author
-
Koupaei, Maryam, Saderi, Horieh, Amin Marashi, Seyed Mahmoud, Fathizadeh, Hadis, and Owlia, Parviz
- Published
- 2022
- Full Text
- View/download PDF
5. Anticancer Effect of Enterocin A-Colicin E1 Fusion Peptide on the Gastric Cancer Cell
- Author
-
Fathizadeh, Hadis, Saffari, Mahmood, Esmaeili, Davoud, Moniri, Rezvan, and Mahabadi, Javad Amini
- Published
- 2021
- Full Text
- View/download PDF
6. Chitosan-based nanoparticles against bacterial infections
- Author
-
Rashki, Somaye, Asgarpour, Kasra, Tarrahimofrad, Hossein, Hashemipour, Maryam, Ebrahimi, Mohammad Saeid, Fathizadeh, Hadis, Khorshidi, Ahmad, Khan, Haroon, Marzhoseyni, Zeynab, Salavati-Niasari, Masoud, and Mirzaei, Hamed
- Published
- 2021
- Full Text
- View/download PDF
7. Study presence of COVID-19 (SARS-CoV-2) in the sweat of patients infected with Covid-19
- Author
-
Fathizadeh, Hadis, Taghizadeh, Sepehr, Safari, Rohollah, Khiabani, Saeid Shabestari, Babak, Bayaz, Hamzavi, Fatemeh, Ganbarov, Khudaverdi, Esposito, Silvano, Zeinalzadeh, Elham, Dao, Sounkalo, Köse, Şükran, and Kafil, Hossein Samadi
- Published
- 2020
- Full Text
- View/download PDF
8. The effects of L-carnitine supplementation on indicators of inflammation and oxidative stress: a systematic review and meta-analysis of randomized controlled trials
- Author
-
Fathizadeh, Hadis, Milajerdi, Alireza, Reiner, Željko, Amirani, Elaheh, Asemi, Zatollah, Mansournia, Mohammad Ali, and Hallajzadeh, Jamal
- Published
- 2020
- Full Text
- View/download PDF
9. Epigenetic roles of PIWI proteins and piRNAs in lung cancer
- Author
-
Fathizadeh, Hadis and Asemi, Zatollah
- Published
- 2019
- Full Text
- View/download PDF
10. Circular RNAs in cancer: new insights into functions and implications in ovarian cancer
- Author
-
Shabaninejad, Zahra, Vafadar, Asma, Movahedpour, Ahmad, Ghasemi, Younes, Namdar, Afshin, Fathizadeh, Hadis, Pourhanifeh, Mohammad Hossein, Savardashtaki, Amir, and Mirzaei, Hamed
- Published
- 2019
- Full Text
- View/download PDF
11. Evaluation of antibacterial activity of enterocin A-colicin E1 fusion peptide
- Author
-
Fathizadeh, Hadis, Saffari, Mahmood, Esmaeili, Davoud, Moniri, Rezvan, and Salimian, Morteza
- Subjects
antibacterial activity ,colicin e1 ,enterocin a ,lcsh:R ,bacteria ,fusion peptide ,lcsh:Medicine ,Original Article ,bacteriocins - Abstract
Objective(s): Bacterial resistance to most common antibiotics is a harbinger of the requirement to find novel anti-infective, antimicrobials agents, and increase innovative strategies to struggle them. Numerous bacteria produce small peptides with antimicrobial activities called bacteriocin. This study aimed to investigate the antibacterial properties of the fusion protein of Enterocin A and Colicin E1 modified against pathogens. Materials and Methods: Analysis of recombinant bacteriocin Enterocin A and Colicin E1 (ent A-col E1) was performed to assay the stability and antibacterial activity of this fusion protein. The pET-22b vector was employed to express the coding sequence of the ent A-col E1 peptide in Escherichia coli BL21 (DE3). Minimum inhibitory concentration (MIC), disk diffusion, and time-kill tests were performed to evaluate the antibacterial activity of the ent A-col E1 against Pseudomonas aeruginosa (ATCC 9027), Escherichia coli (ATCC 10536), Enterococcus faecalis (ATCC 29212), and Staphylococcus aureus (ATCC 33591). Results: The suggested recombinant peptide had good antibacterial activity against both Gram-negative and Gram-positive pathogens. It has also good stability at various temperatures, pH levels, and salt concentrations. Conclusion: Because bacteriocins are harmless compounds, they can be recommended as therapeutic or preventive supplements to control pathogens. According to the obtained results, the ent A-col E1 peptide can serve as an efficient antibacterial compound to treat or prevent bacterial infections.
- Published
- 2020
12. Colistin resistance mechanisms in Gram-negative bacteria: a Focus on Escherichia coli.
- Author
-
Abavisani, Mohammad, Bostanghadiri, Narjess, Ghahramanpour, Hossein, Kodori, Mansoor, Akrami, Fariba, Fathizadeh, Hadis, Hashemi, Ali, and Rastegari-Pouyani, Mohsen
- Subjects
COLISTIN ,ESCHERICHIA coli ,GRAM-negative bacteria ,POLYMYXIN ,KLEBSIELLA pneumoniae ,ANTIBIOTICS - Abstract
Multidrug-resistant (MDR) Escherichia coli strains have rapidly increased worldwide, and effective antibiotic therapeutic options are becoming more restricted. As a polymyxin antibiotic, colistin has a long history of usage, and it is used as a final line of treatment for severe infections by Gram-negative bacteria (GNB) with high-level resistance. However, its application has been challenged by the emergence of E. coli colistin resistance. Hence, determining the mechanism that confers colistin resistance is crucial for monitoring and controlling the dissemination of colistin-resistant E. coli strains. This comprehensive review summarizes colistin resistance mechanisms in E. coli strains and concentrates on the history, mode of action, and therapeutic implications of colistin. We have mainly focused on the fundamental mechanisms of colistin resistance that are mediated by chromosomal or plasmid elements and discussed major mutations in the two-component systems (TCSs) genes and plasmids that transmit the mobilized colistin resistance resistant genes in E. coli strains. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
13. Prevalence of needle stick and its related factors in Iranian health worker: an updated systematic review and meta-analysis.
- Author
-
Fathizadeh, Hadis, Alirezaie, Zahra, Saeed, Fatemeh, Saeed, Bita, Gharibi, Zahra, and Biojmajd, Abdol R.
- Subjects
HEPATITIS C risk factors ,HIV infection risk factors ,NEEDLESTICK injuries ,HEPATITIS B ,INTENSIVE care units ,ONLINE information services ,SHIFT systems ,META-analysis ,CONFIDENCE intervals ,HOSPITAL emergency services ,SYSTEMATIC reviews ,MEDICAL personnel ,PSYCHOSOCIAL factors ,DESCRIPTIVE statistics ,DISEASE prevalence ,MEDLINE ,DATA analysis software ,BLOODBORNE infections ,DISEASE risk factors ,DISEASE complications - Abstract
Background Healthcare workers (HCWs) are at risk of acquiring blood-borne infections such as hepatitis B, hepatitis C, and human immunodeficiency virus through needlestick injuries (NSIs). We aimed to investigate the prevalence of needlestick injuries and other related indicators among HCWs in Iran through a systematic review and meta-analysis. Methods We searched various databases until the end of May 2023 for studies reporting the prevalence of NSIs among healthcare workers in Iran. We used a random model with 95% confidence intervals (CIs) to analyse the data and the Joanna Briggs Institute (JBI) tool to evaluate the quality of included studies. We conducted and reported the study according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. Results We included 87 studies in the analysis and found that 47% (95% CI = 42-52, I2 = 98.9%) of Iranian HCWs experienced NSI. NSIs were most frequently related to syringe needles (58%; 95% CI = 52-65, I2 = 96.8%) and most often caused by recapping (30%; 95% CI = 22-38, I2 = 98.5%). In this study, 56% (95% CI = 45-67, I2 = 98.6%) of HCWs with NSIs did not report their injury. Moreover, the prevalence of NSIs the highest in the morning shift (0.44; 95% CI = 0.36-0.53, I2 = 97.2%), emergency unit (0.20; 95% CI = 0.16-0.24, I2 = 93.7%), and intensive care unit (0.20; 95% CI = 0.16-0.24, I2 = 94.3%). Conclusions To reduce the high prevalence of NSIs, HCWs, especially those in emergency departments, should use safety equipment. Healthcare managers should provide a calm and stress-free environment for HCWs, educate them on safety principles and standards, and support experienced HCWs with NSIs. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
14. Antimicrobial effect of silver and gold nanoparticles in combination with linezolid on Enterococcus biofilm.
- Author
-
Sabzi, Niloofar, Moniri, Rezvan, Sehat, Mojtaba, Fathizadeh, Hadis, and Nazari-Alam, Ali
- Subjects
GOLD nanoparticles ,SILVER nanoparticles ,LINEZOLID ,FOURIER transform infrared spectroscopy ,MATRIX-assisted laser desorption-ionization ,BIOFILMS - Abstract
Background and Objectives: In the past few years, application of new antimicrobial e.g. nanoparticles (NPs) to treat infection caused by drug-resistant bacteria has increased. This study aimed to determine antimicrobial property of silver nanoparticles (AgNPs) and gold nanoparticles (AuNPs) in combination with linezolid on Enterococcus biofilm. Materials and Methods: A total of forty-eight isolates of Enterococcus spp. were collected and confirmed by PCR method. The synthesis of biocompatible AgNPs was performed, then analyzed by Fourier Transform Infrared spectroscopy (FTIR), Scanning Electron Microscopy (SEM), and Transmission Electron Microscopy. We carried out minimum inhibitory concentration (MIC) and biofilm forming capacity of AgNPs and AuNPs with linezolid. Results: Twenty-two E. faecium isolates and twenty- six E. faecalis investigated in this study. Strong biofilm formation was seen in 12 (25%) of isolates, and others isolates (75%) formed moderate biofilm. AgNPs and Au-NPs size were 26 nm and 20 nm respectively. The MIC of AgNPs was 23.2 μg/ml, and AuNPs were 92.1 μg/ml and the lowest MIC was obtained 2 μg/ml in linezolid. Biofilm formation inhibitory activity by AuNPs + Linezolide and AgNPs + Linezolide 70 to 80 percent increased in average. Conclusion: The antibiofilm activity of AgNPs and AuNPs increased when both agents were used in combination with linezolid in comparison with each agent alone. [ABSTRACT FROM AUTHOR]
- Published
- 2022
15. Antimicrobial Resistance Profile of Extended-spectrum Beta-lactamase Genes in Escherichia coli Isolates Using Multiplex PCR Technique.
- Author
-
Raiszadeh, Mohammad, Khosravi, Mohamad Ali, Fathizadeh, Hadis, Khodaparast, Morteza, Ghiasi, Seyyed Mohammad Saeed, and Esmaeili, Davoud
- Subjects
ESCHERICHIA coli ,BETA-lactamase inhibitors ,POLYMERASE chain reaction ,DRUG resistance in microorganisms ,DNA primers - Abstract
Background: Broad-spectrum antibiotic resistance genes are one of the most common developing resistance genes worldwide. Accordingly, it is of paramount importance to study the extended-spectrum beta-lactamase genes to report them to physicians to select the most appropriate treatment. Objectives: This study aimed to detect three genes of ESBL such as TEM, AmpC, and KPC simultaneously. Methods: Primers were designed for ESBL genes such as TEM, AmpC, and KPC with Genscript software. In this study, control-positive genes were used for the PCR set-up. Fifty isolates of Escherichia coli isolated in the Baqiyatallah Hospital were confirmed and checked by Multiplex PCR. Results: This study revealed that TEM, AmpC, and KPC primers could detect positive control genes. The sensitivity and specificity of the multiplex PCR technique for these genes were 0.001 ng and 100%, respectively. Conclusions: This study revealed that a Multiplex PCR with a sensitivity of 0.001 ng and 100% specificity can detect ESBL genes precisely. Accordingly, the rapid and precise detection of the antibiotic resistance genes and the recommendation of an appropriate treatment pattern can decrease the distribution of antibiotic resistance occurrence and economic cost. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
16. Recent Advances in Nanotechnology for the Management of Klebsiella pneumoniae –Related Infections.
- Author
-
Barani, Mahmood, Fathizadeh, Hadis, Arkaban, Hassan, Kalantar-Neyestanaki, Davood, Akbarizadeh, Majid Reza, Turki Jalil, Abduladheem, and Akhavan-Sigari, Reza
- Subjects
KLEBSIELLA pneumoniae ,URINARY tract infections ,NANOTECHNOLOGY ,NANOBIOTECHNOLOGY ,INFECTION - Abstract
Klebsiella pneumoniae is an important human pathogen that causes diseases such as urinary tract infections, pneumonia, bloodstream infections, bacteremia, and sepsis. The rise of multidrug-resistant strains has severely limited the available treatments for K. pneumoniae infections. On the other hand, K. pneumoniae activity (and related infections) urgently requires improved management strategies. A growing number of medical applications are using nanotechnology, which uses materials with atomic or molecular dimensions, to diagnose, eliminate, or reduce the activity of different infections. In this review, we start with the traditional treatment and detection method for K. pneumoniae and then concentrate on selected studies (2015–2022) that investigated the application of nanoparticles separately and in combination with other techniques against K. pneumoniae. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
17. Bismuth nanoparticles against microbial infections.
- Author
-
Neamati, Foroogh, Kodori, Mansoor, Feizabadi, Mohammad Mehdi, Abavisani, Mohammad, Barani, Mohammad, Khaledi, Mansoor, Moghadaszadeh, Masoud, Azadbakht, Mohammad Karim, Zeinali, Mojdeh, and Fathizadeh, Hadis
- Abstract
The destructive effect of infectious diseases on human life and the emergence of antibiotic-resistant strains highlight the importance of developing new and appropriate treatment strategies, one of which is the use of metals as therapeutic agents. Bismuth nanoparticles are an example of prominent metal-containing drugs. The therapeutic effects of bismuth-based drugs in the treatment of wounds have been proven. Various laboratory studies have confirmed the antimicrobial effects of bismuth nanoparticles, including the clinical treatment of ulcers caused by Helicobacter pylori. Therefore, considering the performance of this nanoparticle and its potent effect on infectious agents and its therapeutic dimensions, the present study fully investigated the properties and performance of this metal-based nanoparticle. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
18. Bacteria-derived chimeric toxins as potential anticancer agents.
- Author
-
Khoshnood, Saeed, Fathizadeh, Hadis, Neamati, Foroogh, Negahdari, Babak, Baindara, Piyush, Abdullah, Mohd Azmuddin, and Haddadi, Mohammad Hossein
- Subjects
BACTERIAL toxins ,TOXINS ,ANTINEOPLASTIC agents ,DRUG resistance ,TREATMENT failure - Abstract
Cancer is one of the major causes of death globally, requiring everlasting efforts to develop novel, specific, effective, and safe treatment strategies. Despite advances in recent years, chemotherapy, as the primary treatment for cancer, still faces limitations such as the lack of specificity, drug resistance, and treatment failure. Bacterial toxins have great potential to be used as anticancer agents and can boost the effectiveness of cancer chemotherapeutics. Bacterial toxins exert anticancer effects by affecting the cell cycle and apoptotic pathways and regulating tumorigenesis. Chimeric toxins, which are recombinant derivatives of bacterial toxins, have been developed to address the low specificity of their conventional peers. Through their targeting moieties, chimeric toxins can specifically and effectively detect and kill cancer cells. This review takes a comprehensive look at the anticancer properties of bacteria-derived toxins and discusses their potential applications as therapeutic options for integrative cancer treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
19. Antimicrobial Activity of Children's Toothpaste on the Bacteria Causing Dental Caries.
- Author
-
Taghdisi-Kashani, Amene, Gholamshahi, Azadeh, Fathizadeh, Hadis, Azadchehr, Mohammadjavad, Rahimi, Mohammadreza, Forouzandeh, Hadi, and Nazari-Alam, Ali
- Subjects
CAVITY prevention ,BACTERIAL disease prevention ,DENTIFRICES ,ENTEROCOCCUS faecium ,LACTOBACILLUS acidophilus ,ANTI-infective agents ,MANN Whitney U Test ,TREATMENT effectiveness ,STREPTOCOCCUS mutans ,MICROBIAL sensitivity tests - Abstract
Background and Aim: Early childhood caries is one of the most common chronic diseases in children, affecting both oral and general health. Oral microorganisms are the most important causative agents associated with dental caries in children. The aim of this study was to compare the antimicrobial activity of common Iranian and non-Iranian children's toothpaste on the growth of four standard bacteria strains, including Streptococcus mutans, Streptococcus sanguinis, Lactobacillus acidophilus, and Enterococcus faecalis. Materials and Methods: In this study, six types of the most common Iranian and non-Iranian children toothpaste produced by different companies were prepared. Different concentrations of toothpaste were prepared according to the Clinical and Laboratory Standards Institute (CLSI) standard. The minimum inhibitory concentration (MIC) and the minimum bactericidal concentration (MBC) of Iranian and non-Iranian children's toothpaste were measured by the microbroth dilution method at ten different concentrations. Results: For the S. mutans bacteria, the lowest MIC was found in Misswake, Vi-One, and 2080 toothpaste. In the case of S. sanguinis and L. acidophilus bacteria, the lowest MIC was related to Frice toothpaste, and for E. faecalis bacteria, the lowest MICs were found for Misswake and 2080 toothpaste. Mann-Whitney U test also revealed that the inhibitory and bactericidal activities of Iranian children's toothpaste on the studied bacteria were not significantly different from those of non-Iranian children's toothpaste. Conclusion: In general, the antimicrobial activity of Iranian children's toothpaste was higher than non-that of Iranian samples. In addition, the MIC of 2080 and Frice toothpaste in the four bacteria examined was lower than in other used toothpaste. To prevent early tooth decay in children use of these two kinds of toothpaste is recommended. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
20. An Update on the Effects of Probiotics on Gastrointestinal Cancers.
- Author
-
Davoodvandi, Amirhossein, Fallahi, Farzaneh, Tamtaji, Omid Reza, Tajiknia, Vida, Banikazemi, Zarrin, Fathizadeh, Hadis, Abbasi-Kolli, Mohammad, Aschner, Michael, Ghandali, Maryam, Sahebkar, Amirhossein, Taghizadeh, Mohsen, and Mirzaei, Hamed
- Subjects
GASTROINTESTINAL cancer ,PROBIOTICS ,INFLAMMATORY bowel diseases ,GUT microbiome ,ADJUVANT treatment of cancer ,SHORT-chain fatty acids - Abstract
Because of their increasing prevalence, gastrointestinal (GI) cancers are regarded as an important global health challenge. Microorganisms residing in the human GI tract, termed gut microbiota, encompass a large number of living organisms. The role of the gut in the regulation of the gut-mediated immune responses, metabolism, absorption of micro- and macro-nutrients and essential vitamins, and short-chain fatty acid production, and resistance to pathogens has been extensively investigated. In the past few decades, it has been shown that microbiota imbalance is associated with the susceptibility to various chronic disorders, such as obesity, irritable bowel syndrome, inflammatory bowel disease, asthma, rheumatoid arthritis, psychiatric disorders, and various types of cancer. Emerging evidence has shown that oral administration of various strains of probiotics can protect against cancer development. Furthermore, clinical investigations suggest that probiotic administration in cancer patients decreases the incidence of postoperative inflammation. The present review addresses the efficacy and underlying mechanisms of action of probiotics against GI cancers. The safety of the most commercial probiotic strains has been confirmed, and therefore these strains can be used as adjuvant or neo-adjuvant treatments for cancer prevention and improving the efficacy of therapeutic strategies. Nevertheless, well-designed clinical studies are still needed for a better understanding of the properties and mechanisms of action of probiotic strains in mitigating GI cancer development. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
21. SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review.
- Author
-
Fathizadeh, Hadis, Afshar, Saman, Masoudi, Mahmood Reza, Gholizadeh, Pourya, Asgharzadeh, Mohammad, Ganbarov, Khudaverdi, Köse, Şükran, Yousefi, Mehdi, and Kafil, Hossein Samadi
- Subjects
- *
COVID-19 , *SARS-CoV-2 , *COVID-19 vaccines , *VACCINE effectiveness , *VACCINES - Abstract
The world has been suffering from COVID-19 disease for more than a year, and it still has a high mortality rate. In addition to the need to minimize transmission of the virus through non-pharmacological measures such as the use of masks and social distance, many efforts are being made to develop a variety of vaccines to prevent the disease worldwide. So far, several vaccines have reached the final stages of safety and efficacy in various phases of clinical trials, and some, such as Moderna/NIAID and BioNTech/Pfizer, have reported very high safety and protection. The important point is that comparing different vaccines is not easy because there is no set standard for measuring neutralization. In this study, we have reviewed the common platforms of COVID-19 vaccines and tried to present the latest reports on the effectiveness of these vaccines. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
22. The effects of L-carnitine supplementation on glycemic control
- Author
-
Fathizadeh, Hadis, Milajerdi, Alireza, Reiner, Željko, Kolahdooz, Fariba, and Asemi, Zatollah
- Subjects
Meta-analysis ,Glycemic control ,L-carnitine ,Insulin resistance - Abstract
The findings of trials investigating the effect of L-carnitine administration on glycemic control are controversial. This meta-analysis of randomized controlled trials (RCTs) was performed to explore the effects of L-carnitine intake on glycemic control. Two authors independently searched electronic databases including MEDLINE, EMBASE, Cochrane Library, Web of Science, PubMed and Google scholar from 1990 until February 2019, in order to find relevant RCTs. 37 studies with 44 effect sizes met the inclusion criteria and were eligible for the meta-analysis. L-carnitine supplementation resulted in a significant reduction in fasting plasma glucose (FPG) (WMD: -4.57; 95 % CI: -6.88, -2.25), insulin (WMD: -1.21; 95 % CI: -1.85, -0.57), homeostatic model assessment for insulin resistance (HOMA-IR) (WMD: -0.67; 95 % CI: -0 .90, -0.44) and HbA1C concentrations (WMD: -0.30; 95 % CI: -0.47, -0.13). L-Carnitine supplementation significantly reduced FPG, insulin, HOMA-IR, and HbA1c levels., EXCLI Journal;Vol. 18 2019
- Published
- 2019
- Full Text
- View/download PDF
23. COVID-19 reinfection in a healthcare worker after exposure with high dose of virus: A case report.
- Author
-
Ahmadian, Shahram, Fathizadeh, Hadis, Khiabani, Saeid Shabestari, Asgharzadeh, Mohammad, and Kafil, Hossein Samadi
- Subjects
- *
MEDICAL personnel , *COVID-19 , *EXPOSURE dose , *REINFECTION , *SYMPTOMS - Abstract
Reinfection with COVID-19 is possible after exposure to a high dose of the virus. Due to immunity acquired during the previous infection, light symptoms are expected. The finding indicates importance of continuous protection in healthcare workers. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
24. Long non-coding RNA molecules in tuberculosis.
- Author
-
Fathizadeh, Hadis, Hayat, Seyed Mohammad Gheibi, Dao, Sounkalo, Ganbarov, Khudaverdi, Tanomand, Asghar, Asgharzadeh, Mohammad, and Kafil, Hossein Samadi
- Subjects
- *
NON-coding RNA , *TUBERCULOSIS , *LINCRNA , *MYCOBACTERIUM tuberculosis , *CELL cycle regulation , *COMMUNICABLE diseases , *SPINAL tuberculosis - Abstract
Tuberculosis (TB), a chronic disease caused by Mycobacterium tuberculosis , is one of the deadliest infectious diseases in the world. Despite significant advances in detection techniques and therapeutic approaches for tuberculosis, there is still no suitable solution for early screening and reducing the number of individuals affected and their effective treatment. Various cellular events can disrupt the development of TB. The basis of these events is dysregulating of genes expression patterns related with specific molecules. Long non-coding RNAs (lncRNAs) are molecules discovered to regulate the expression of protein-coding genes and participate in gene silencing, cell cycle regulation and cellular differentiation processes. Dysregulation of lncRNAs has been found to be associated with many diseases, including cancers and infectious diseases. Thus, the recognition of lncRNAs as novel molecular biomarkers and therapeutic targets for tuberculosis is promising. In the present review, we try to summarize the current findings of lncRNA expression patterns and its role in tuberculosis infection process. Unlabelled Image [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
25. Protection and disinfection policies against SARS-CoV-2 (COVID-19).
- Author
-
Fathizadeh, Hadis, Maroufi, Parham, Momen-Heravi, Mansooreh, Dao, Sounkalo, Köse, Sükran, Ganbarov, Khudaverdi, Pagliano, Pasquale, Espsoito, Silvano, and Kafil, Hossein Samadi
- Published
- 2020
26. THE EFFECTS OF L-CARNITINE SUPPLEMENTATION ON GLYCEMIC CONTROL: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS.
- Author
-
Asemi, Zatollah, Fathizadeh, Hadis, Kolahdooz, Fariba, Milajerdi, Alireza, and Reiner, Željko
- Subjects
- *
GLYCEMIC control , *RANDOMIZED controlled trials , *META-analysis , *UBIQUINONES , *INSULIN resistance , *DATABASE searching - Abstract
The findings of trials investigating the effect of L-carnitine administration on glycemic control are controversial. This meta-analysis of randomized controlled trials (RCTs) was performed to explore the effects of L-carnitine intake on glycemic control. Two authors independently searched electronic databases including MEDLINE, EMBASE, Cochrane Library, Web of Science, PubMed and Google scholar from 1990 until February 2019, in order to find relevant RCTs. 37 studies with 44 effect sizes met the inclusion criteria and were eligible for the metaanalysis. L-carnitine supplementation resulted in a significant reduction in fasting plasma glucose (FPG) (WMD: -4.57; 95 % CI: -6.88, -2.25), insulin (WMD: -1.21; 95 % CI: -1.85, -0.57), homeostatic model assessment for insulin resistance (HOMA-IR) (WMD: -0.67; 95 % CI: -0.90, -0.44) and HbA1C concentrations (WMD: -0.30; 95 % CI: -0.47, -0.13). L-Carnitine supplementation significantly reduced FPG, insulin, HOMA-IR, and HbA1c levels. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
27. Circular RNAs as diagnostic biomarker in pancreatic cancer.
- Author
-
Fathizadeh, Hadis, Hallajzadeh, Jamal, and Asemi, Zatollah
- Subjects
- *
PANCREATIC cancer , *CIRCULAR RNA , *BIOMARKERS , *TUMOR classification , *NON-coding RNA , *METASTASIS - Abstract
Pancreatic cancer is one of the causes of death in the world. Unfortunately, common imaging technologies did not succeed in identifying this disease, and because of the absence of sensitive and specific biomarkers, it is not possible to screen and diagnose the disease. Therefore, this disease is usually diagnosed when patient is at an advanced stage of cancer and has lost the chance of surgery, and routine treatments such as radiotherapy and chemotherapy are not very effective. For this reason, the discovery of new biomarkers to overcome the diagnostic and therapeutic problems of pancreatic cancer is essential. Recently, circular RNAs (circRNAs) have been introduced as a group of noncoding RNAs that can play the role of critical regulators in various human diseases including cancer. A lot of studies revealed that circRNAs can have diverse roles in various cancers, including breast, colorectal, lung, renal, gastric, and hepatocellular carcinoma. The results of these researches have demonstrated that change in circRNAs expression levels in the tumor cells affects carcinogenesis, the stages of progression and metastasis of cancer through various mechanisms. Given that several studies have tested the role of circRNAs in pancreatic cancer, we decided to review the mechanisms proposed in these studies to conclude and summarize the work done in this regard. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
28. Melatonin: an anti-tumor agent for osteosarcoma.
- Author
-
Fathizadeh, Hadis, Mirzaei, Hamed, and Asemi, Zatollah
- Subjects
- *
MELATONIN , *BONE cancer , *SURGICAL excision , *PINEAL gland , *OSTEOSARCOMA , *BONE tumors - Abstract
Osteosarcoma is the most common bone tumors which consisted of malignant mesenchymal cells generating osteoid and immature bone. It has been showed that osteosarcoma is common in children and adolescents and shows high mortality rate. A variety of therapeutic approaches (i.e., resection surgery, combined with chemotherapy and radiotherapy) have been used as conventional treatments in patients with osteosarcoma. Despite several attempts to improve therapeutic response, the rate of survival for osteosarcoma has not changed during the past 3 decades. Therefore, the discovery and developing new effective therapeutic platforms are required. Along to the established anti-cancer agents, some physiological regulators such melatonin, have been emerged as new anti-cancer agents. Melatonin is an indolamine hormone which is secreted from the pineal glands during the night and acts as physiological regulator. Given that melatonin shows a wide spectrum anti-tumor impacts. Besides different biologic activities of melatonin (e.g., immunomodulation and antioxidant properties), melatonin has a crucial role in the formation of bones, and its deficiency could be directly related to bone cancers. Several in vitro and in vivo experiments evaluated the effects of melatonin on osteosarcoma and other types of bone cancer. Taken together, the results of these studies indicated that melatonin could be introduced as new therapeutic candidate or as adjuvant in combination with other anti-tumor agents in the treatment of osteosarcoma. Herein, we summarized the anti-tumor effects of melatonin for osteosarcoma cancer as well as its mechanism of action. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
29. Circular RNAs and tuberculosis infection.
- Author
-
Hemati, Zahra, Neamati, Foroogh, Khaledi, Mansoor, Gheibihayat, Seyed Mohammad, Jafarzadeh, Leila, Momen-Heravi, Mansooreh, Haddadi, Mohammad Hossein, Sameni, Fatemeh, and Fathizadeh, Hadis
- Subjects
- *
CIRCULAR RNA , *TUBERCULOSIS , *MYCOBACTERIUM tuberculosis , *COMMUNICABLE diseases , *DIAGNOSIS , *INFECTION - Abstract
Tuberculosis (TB) is a deadly infectious disease caused by Mycobacterium tuberculosis (Mtb) that affects the immune system chronically. Therefore, effective control and treatment of tuberculosis requires rapid and accurate diagnostic strategies. Tuberculosis has always been a global burden on health, social and economic systems due to the lack of standard curative and diagnostic (bio)markers. Accordingly, the management and monitoring of patients with active TB at the primary care level may be possible through new, rapid and cost-effective non-sputum-based diagnostic procedures. Biomarkers can help diagnose various diseases, including circular RNA (circRNA), which has recently been introduced as an endogenous, abundant and stable RNA in the cytoplasm with unique tissue specificity. There are frequent reports of circRNA involvement in many pathological and physiological processes in human beings. Recent studies have highlighted the presence of circRNAs in serum and their role as promising biomarkers in the diagnosis of the disease, potentially due to the continuous, stable, closed covalent circular structures and lack of easy degradation by nucleases. The purpose of this review article is to scrutinize the behavior of circulating plasma RNAs in relation to the pathogenesis and diagnosis of tuberculosis. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
30. Bacteriocins: Recent Advances in its Application as an Antimicrobial Alternative.
- Author
-
Fathizadeh H, Pakdel F, Saffari M, Esmaeili D, Heravi MM, Dao S, Ganbarov K, and Kafil HS
- Subjects
- Anti-Bacterial Agents pharmacology, Anti-Bacterial Agents therapeutic use, Bacteria, Humans, Peptides, Bacterial Infections, Bacteriocins pharmacology, Bacteriocins therapeutic use
- Abstract
Due to the emergence and development of antibiotic resistance in the treatment of bacterial infections, efforts to discover new antimicrobial agents have increased. One of these antimicrobial agents is a compound produced by a large number of bacteria called bacteriocin. Bacteriocins are small ribosomal polypeptides that can exert their antibacterial effects against bacteria close to their producer strain or even non-closely-relatedstrains. Adequate knowledge of the structure and functional mechanisms of bacteriocins and their spectrum of activity, as well as knowledge of the mechanisms of possible resistance to these compounds, will lead to further development of their use as an alternative to antibiotics. Furthermore, most bacteria that live in the gastrointestinal tract (GIT) have the ability to produce bacteriocins, which spread throughout the GIT. Despite antimicrobial studies in vitro, our knowledge of bacteriocins in the GIT and the migration of these bacteriocins from the epithelial barrier is low. Hence, in this study, we reviewed general information about bacteriocins, such as classification, mechanism of action and resistance, emphasizing their presence, stability, and spectrum of activity in the GIT., (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.)
- Published
- 2022
- Full Text
- View/download PDF
31. Bacteriocins: New Potential Therapeutic Candidates in Cancer Therapy.
- Author
-
Fathizadeh H, Saffari M, Esmaeili D, Moniri R, and Kafil HS
- Subjects
- Gene Expression Regulation, Neoplastic drug effects, Humans, Neoplasms genetics, Neoplasms pathology, Nisin therapeutic use, Pediocins therapeutic use, Pyocins therapeutic use, Signal Transduction drug effects, Antineoplastic Agents therapeutic use, Bacteriocins therapeutic use, Neoplasms drug therapy
- Abstract
Cancer is one of the most important disorders which is associated with high mortality and high costs of treatment for patients. Despite several efforts, finding, designing and developing, new therapeutic platforms in the treatment of cancer patients are still required. Utilization of microorganisms, particularly bacteria has emerged as new therapeutic approaches in the treatment of various cancers. Increasing data indicated that bacteria could be used in the production of a wide range of anti-cancer agents, including bacteriocins, antibiotics, peptides, enzymes, and toxins. Among these anti-cancer agents, bacteriocins have attractive properties, which make them powerful anti-cancer drugs. Multiple lines evidence indicated that several bacteriocins (i.e., colcins, nisins, pediocins, pyocins, and bovocins) via activation/inhibition different cellular and molecular signaling pathways are able to suppress tumor growth in various stages. Hence, identification and using various bacteriocins could lead to improve and introduce them to clinical practices. Here, we summarized various bacteriocins which could be employed as anti-cancer agents in the treatment of many cancers., (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.)
- Published
- 2021
- Full Text
- View/download PDF
32. Bacterial Etiology and Antibiotic Susceptibility of Conjunctivitis Patients' Isolates in Kashan, Iran.
- Author
-
Shaeri M, Nazari-Alam A, Fathizadeh H, Moniri R, Akbari H, Mansoori M, and Aghajani A
- Abstract
Background: Conjunctivitis is a very common ocular disease, which can be caused by a wide variety of microorganisms. This study was aimed to assess the bacterial etiology and antibiotic susceptibility of conjunctivitis patients' isolates from Central Iran., Materials and Methods: This study was performed in 180 patients referred to the Department of Ophthalmology in Kashan University with symptoms of conjunctivitis from July 2017 to December 2017. To detect of different bacteria, Gram staining, morphological characterization, pigment production, biochemical characteristics, coagulase test, optochin and PYR tests, oxidase test, and culture on specific media were used. Antibiotic susceptibility of the bacteria isolated was done using the Kirby-Bauer method. Methicillin resistance in staphylococci isolated from the patients was identified using polymerase chain reaction technique., Results: Of the 195 bacteria isolated, about 81.5% were Staphylococcus epidermidis and Staphylococcus aureus and the remaining 19.5% included other species. In the present study, Pseudomonas aeruginosa was most resistant to ampicillin. In the case of S. epidermidis and S. aureus , the highest resistance was observed against erythromycin and the least resistance was against rifampicin and linezolid., Conclusion: In this study, S. aureus and S. epidermidis are the most common causes of conjunctivitis in all age groups, however, this condition decreases with age and is also influenced by other factors such as season and weather conditions. The results of this study can be helpful in planning more prudent treatment strategies for patients with conjunctivitis in Kashan., Competing Interests: There are no conflicts of interest., (Copyright: © 2020 Advanced Biomedical Research.)
- Published
- 2020
- Full Text
- View/download PDF
33. Circular RNA and Diabetes: Epigenetic Regulator with Diagnostic Role.
- Author
-
Abbaszadeh-Goudarzi K, Radbakhsh S, Pourhanifeh MH, Khanbabaei H, Davoodvandi A, Fathizadeh H, Sahebkar A, Shahrzad MK, and Mirzaei H
- Subjects
- Animals, Diabetes Mellitus genetics, Humans, Prognosis, Diabetes Mellitus diagnosis, Epigenesis, Genetic, MicroRNAs genetics, RNA, Circular genetics
- Abstract
Circular RNAs, a group of endogenous non-coding RNAs, are characterized by covalently closed cyclic structures with no poly-adenylated tails. It has been recently recommended that cirRNAs have an essential role in regulating genes expression by functioning as a translational regulator, RNA binding protein sponge and microRNA sponge. Due to their close relation to the progression of various diseases such as diabetes, circRNAs have become a research hotspot. A number of circRNAs (i.e., circRNA_0054633, circHIPK3, circANKRD36, and circRNA11783-2) have been shown to be associated with initiation and progression of diabetes. Based on reports, in a tissue, some circRNAs are expressed in a developmental stage-specific manner. In this study, we reviewed research on circular RNAs involved in the pathogenesis and diagnosis of diabetes and their prognostic roles., (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.)
- Published
- 2020
- Full Text
- View/download PDF
34. Protection and disinfection policies against SARS-CoV-2 (COVID-19).
- Author
-
Fathizadeh H, Maroufi P, Momen-Heravi M, Dao S, Köse Ş, Ganbarov K, Pagliano P, Esposito S, and Kafil HS
- Subjects
- Betacoronavirus drug effects, Betacoronavirus isolation & purification, COVID-19, Coronavirus Infections epidemiology, Humans, Pneumonia, Viral epidemiology, SARS-CoV-2, Betacoronavirus physiology, Coronavirus Infections prevention & control, Disinfectants administration & dosage, Disinfection methods, Environmental Microbiology, Pandemics prevention & control, Personal Protective Equipment, Pneumonia, Viral prevention & control
- Abstract
In late December 2019, reports from China of the incidence of pneumonia with unknown etiology were sent to the World Health Organization (WHO). Shortly afterwards, the cause of this disease was identified as the novel beta-coronavirus, SARS-CoV-2, and its genetic sequence was published on January 12, 2020. Human-to-human transmission via respiratory droplets and contact with aerosol infected surfaces are the major ways of transmitting this virus. Here we attempted to collect information on virus stability in the air and on surfaces and ways of preventing of SARS-CoV-2 spreading.
- Published
- 2020
35. The effects of L-carnitine supplementation on glycemic control: a systematic review and meta-analysis of randomized controlled trials.
- Author
-
Fathizadeh H, Milajerdi A, Reiner Ž, Kolahdooz F, and Asemi Z
- Abstract
The findings of trials investigating the effect of L-carnitine administration on glycemic control are controversial. This meta-analysis of randomized controlled trials (RCTs) was performed to explore the effects of L-carnitine intake on glycemic control. Two authors independently searched electronic databases including MEDLINE, EMBASE, Cochrane Library, Web of Science, PubMed and Google scholar from 1990 until February 2019, in order to find relevant RCTs. 37 studies with 44 effect sizes met the inclusion criteria and were eligible for the meta-analysis. L-carnitine supplementation resulted in a significant reduction in fasting plasma glucose (FPG) (WMD: -4.57; 95 % CI: -6.88, -2.25), insulin (WMD: -1.21; 95 % CI: -1.85, -0.57), homeostatic model assessment for insulin resistance (HOMA-IR) (WMD: -0.67; 95 % CI: -0.90, -0.44) and HbA1C concentrations (WMD: -0.30; 95 % CI: -0.47, -0.13). L-Carnitine supplementation significantly reduced FPG, insulin, HOMA-IR, and HbA1c levels., (Copyright © 2019 Fathizadeh et al.)
- Published
- 2019
- Full Text
- View/download PDF
36. The Effects of L-Carnitine Supplementation on Serum Lipids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Author
-
Fathizadeh H, Milajerdi A, Reiner Ž, Kolahdooz F, Chamani M, Amirani E, and Asemi Z
- Subjects
- Cholesterol, HDL blood, Cholesterol, LDL blood, Dietary Supplements, Humans, Randomized Controlled Trials as Topic, Triglycerides blood, Carnitine administration & dosage, Lipids blood
- Abstract
Background: The findings of trials investigating the effects of L-carnitine administration on serum lipids are inconsistent. This meta-analysis of randomized controlled trials (RCTs) was performed to summarize the effects of L-carnitine intake on serum lipids in patients and healthy individuals., Methods: Two authors independently searched electronic databases including MEDLINE, EMBASE, Cochrane Library, Web of Science, PubMed and Google Scholar from 1990 until August 1, 2019, in order to find relevant RCTs. The quality of selected RCTs was evaluated using the Cochrane Collaboration risk of bias tool. Cochrane's Q test and I-square (I2) statistic were used to determine the heterogeneity across included trials. Weight mean difference (SMD) and 95% CI between the two intervention groups were used to determine pooled effect sizes. Subgroup analyses were performed to evaluate the source of heterogeneity based on suspected variables such as, participant's health conditions, age, dosage of L-carnitine, duration of study, sample size, and study location between primary RCTs., Results: Out of 3460 potential papers selected based on keywords search, 67 studies met the inclusion criteria and were eligible for the meta-analysis. The pooled results indicated that L-carnitine administration led to a significant decrease in triglycerides (WMD: -10.35; 95% CI: -16.43, -4.27), total cholesterol (WMD: -9.47; 95% CI: - 13.23, -5.70) and LDL-cholesterol (LDL-C) concentrations (WMD: -6.25; 95% CI: -9.30, -3.21), and a significant increase in HDL-cholesterol (HDL-C) levels (WMD: 1.39; 95% CI: 0.21, 2.57). L-carnitine supplementation did not influence VLDL-cholesterol concentrations. When we stratified studies for the predefined factors such as dosage, and age, no significant effects of the intervention on triglycerides, LDL-C, and HDL-C levels were found., Conclusion: This meta-analysis demonstrated that L-carnitine administration significantly reduced triglycerides, total cholesterol and LDL-cholesterol levels, and significantly increased HDL-cholesterol levels in the pooled analyses, but did not affect VLDL-cholesterol levels; however, these findings were not confirmed in our subgroup analyses by participant's health conditions, age, dosage of L-carnitine, duration of study, sample size, and study location., (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.)
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.